CNS Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Business Outlook
- Friday, August 13, 2021, 7:06
- Finance
- Add a comment
HOUSTON, Aug. 13, 2021 /PRNewswire/ — CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) (“CNS” or the “Company”), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system (CNS), today reported its…
About the Author
adminasapcorp has written 41789 stories on this site.